NCT06846606
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06846606
Title Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Auron Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.